Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines (EV-010) First published 29/07/2022 Last updated 10/02/2023 EU PAS number:EUPAS48390 Study Planned